Clinical trial
Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study
NCT07177326 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study
- Lead sponsor
- Assiut University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- October 1, 2025
- Completion date
- December 1, 2026
- Enrollment
- 142 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.